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In rat isolated mesenteric beds that were contracted with NA as an in vitro model of the vascular adrenergic hyperactivity that
usuallyprecedestheonsetofprimaryhypertension,theoraladministration(3dailydoses)ofeither10mg/kggenisteinor20mg/kg
daidzein potentiated the anandamide-induced reduction of contractility to NA in female but not in male rats. Oral treatment with
phytoestrogens also restored the vascular eﬀects of anandamide as well as the mesenteric content of calcitonin gene-related peptide
(CGRP) that were reduced after ovariectomy. The enhancement of anandamide eﬀects caused by phytoestrogens was prevented by
the concomitant administration of the estrogen receptor antagonist fulvestrant (2.5mg/kg, s.c., 3 daily doses). It is concluded that,
in the vasculature of female rats, phytoestrogens produced an estrogen-receptor-dependent enhancement of the anandamide-
vascular actions that involves the modulation of CGRP levels and appears to be relevant whenever an adrenergic hyperactivity
occurs.
1.Introduction
Endocannabinoids contribute to reduce vascular contractil-
ity under pathological conditions where vascular responsive-
ness is altered. Hence, compounds that selectively modulate
the action as well as the levels of endocannabinoids represent
templates for potential new therapeutic strategies [1]. In this
sense, the exogenous administration of the endocannabinoid
anandamide is known to induce the decrease of blood
pressure in spontaneously hypertensive rats [2]a sw e l la s
in Wistar rats fed with a high-salt diet [3]. Inhibition
of the fatty acid amide hydrolase, enzyme involved in
intracellular anandamide degradation, normalizes the car-
diovascular function in hypertensive rats without producing
adverse metabolic eﬀects [4]. Estrogens are also positive
modulators of the anandamide eﬀects at the vascular wall
since they stimulate the release of anandamide from human
endothelial cells [5] as well as potentiate the anandamide-
induced vasorelaxations by increasing the bioavailability of
the calcitonin-related peptide (CGRP) in the rat mesenteric
vasculature [6]. This potent vasodilator peptide is released,
at least in part, as a consequence of the activation of the
transient receptor potential vanilloid type 1 (TRPV1) by
anandamide [7].
Phytoestrogens, such as genistein and daidzein, are
able to activate estrogen receptors which confer to them
weak estrogen-like activity [8]. They are associated with a
favorable cardiovascular risk proﬁle [9] and therefore con-
stitute an interesting food-based alternative to the hormone
replacement therapy during the menopausal transition in
women [10].Sinceinavarietyofratcelllinesphytoestrogens
inhibit anandamide uptake by blocking the fatty acid amide
hydrolase [11],itispossiblethatphytoestrogensalsoregulate
the vascular eﬀects of anandamide. Hence, the aim of the2 International Journal of Hypertension
present study was to elucidate whether oral administration
of the soy-derived phytoestrogens genistein and daidzein
modulates the anandamide-induced reductions of the con-
tractions to NA in the rat isolated mesenteric bed that was
used as an in vitro model of the adrenergic hyperactivity that
usually precedes the onset of primary hypertension [12].
Thehypothesisisthattheendocannabinoidsystemcould
be another target, in addition to nitric oxide, prostanoids,
and antioxidant defense genes, for the beneﬁcial cardiovas-
cular actions proposed for phytoestrogens [13, 14].
2.MaterialsandMethods
2.1. Animals. Male and female Sprague-Dawley rats were
housed under a 12:12h light: dark cycle, at controlled room
temperature with food and water ad libitum. Experiments
were conducted in accordance to the Guide for the Care and
Use of Laboratory Animals of the National Research Council
(USA, 1996). Adult female rats (8–10 weeks, 165–200g body
weight) were either bilaterally ovariectomized (OVX) or
sham-operated through dorsal incision, under anaesthesia
(40–60mg/kg ketamine hydrochloride + 10mg/kg xylazine
hydrochloride). After 21 days of endogenous hormonal
decline, the animals were randomly allocated to either drug-
treated or vehicle-treated groups.
2.2. Animal Treatments. Dose and duration of treatment
with phytoestrogens were selected on the basis that they
reverted partially, but signiﬁcantly the uterine atrophy
caused by ovariectomy that is considered a parameter of es-
trogenicactivity[15].Accordingtothis,genistein(10mg/kg)
or daidzein (10–20mg/kg) was administered by oral gavage
(p.o.) once daily during three days. Drugs were dissolved
in dimethylsulfoxide (residual concentration <1%) and were
diluted in corn oil. Some intact as well as OVX female rats
treated with phytoestrogen received concomitant subcuta-
neous administrations of the estrogen receptor antagonist
2.5mg/kg fulvestrant (ICI 182,780) dissolved in ethanol and
diluted in corn oil. All groups were analyzed by comparison
with the corresponding vehicle-treated animals.
2.3. Mesenteric Vascular Bed Preparation. Adult male (250–
350g) and female (230–350g) Sprague-Dawley rats were
anaesthetized with urethane (1.2gkg−1 body weight), the
abdomen was opened, and the mesenteric vascular bed was
cannulated and removed according to [16]. The isolated
mesenteric bed was transferred to a perspex chamber and
perfused with the Krebs solution at 37◦C bubbled with 95%
O2 plus 5% CO2 at a constant ﬂow rate of 2mL/min, main-
tained by a peristaltic pump. Changes in vascular resistance
weremeasuredaschangesinperfusionpressureandrecorded
through a Statham pressure transducer connected to a Grass
polygraph. Up to nine consecutive, 20min apart bolus
injections of noradrenaline (NA) were performed in one
preparation because the short contractile responses induced
by this drug are highly reproducible. On the contrary,
the sustained contractions that are obtained whenever the
Table 1: Noradrenaline-induced contractions.
Group n NA-induced contraction
(mmHg)
Male rats
Control 6 51.39 ± 8.46
Vehicle for phytoestrogens 7 52.50 ± 4.72
10mg/kg genistein 4 43.75 ± 6.38
10mg/kg daidzein 5 62.5 ± 9.68
Intact female rats
Control 6 53.54 ± 8.08
Vehicle for phytoestrogens 5 47.68 ± 6.67
10mg/kg genistein 4 51.88 ± 4.72
10mg/kg daidzein 6 55.42 ± 5.02
20mg/kg daidzein 5 53.80 ± 1.70
Ovariectomized female rats
Control 8 52.81 ± 3.61
Vehicle for phytoestrogens 4 41.25 ± 6.49
Vehicle for 17β-oestradiol 6 43.76 ± 4.55
10mg/kg genistein 4 56.25 ± 11.48
10mg/kg daidzein 4 55.00 ± 8.42
20mg/kg daidzein 4 47.50 ± 4.50
450μg/kg 17β-oestradiol 6 52.50 ± 9.64
agonists are added to the perfusate are diﬃcult to reproduce
in the same preparation [17].
Table 1 shows that the contractile responses to NA in
the mesenteric bed had similar magnitudes between the
groups (e.g., males and intact and ovariectomized females).
Moreover, phytoestrogen treatment did not modify per se
either the basal tone or the reactivity to NA; respect to the
vehicle-treated groups.
To evaluate anandamide-induced eﬀect, after the ﬁrst
NA bolus injection considered as control, cumulative anan-
damideconcentrationswereperfusedduring20min,andthe
responsiveness to NA (a submaximal pressor eﬀect, i.e., 40
to 60mmHg) was challenged on every one concentration.
Anandamide was dissolved in ethanol (<0.1%), and further
dilutionsweremadeintheKrebssolution.Noeﬀectsonbasal
tone of mesenteries isolated from either male or female rats
were observed for any concentration of anandamide.
2.4. Immunohistochemistry for CGRP. The experiments were
performed according to [6]. Deeply anaesthetized rats were
ﬁxed by transcardiac perfusion with PBS containing 4%
w/v paraformaldehyde, and mesenteric vascular beds were
dissected. The endogenous peroxidase activity was blocked
with 1% H2O2, and the preparations were permeabilized
with 0.2% Triton X-100. Overnight incubation at room tem-
perature with 1/3,000 anti-CGRP antibody (Sigma Aldrich,
St. Louis, MI, USA) and 1h incubation with 1/200 goat
anti-rabbit peroxidase conjugated antibody (Sigma Aldrich,
St. Louis, MI, USA) were performed. Several branches of
each mesenteric bed were not incubated with the primary
antibody to obtain the corresponding controls. PeroxidaseInternational Journal of Hypertension 3
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Figure 1: Eﬀects of 3-day oral administration of 10mg/kg genistein (ﬁlled circles) on anandamide-induced reductions of contractile
responses to NA in mesenteric vascular beds isolated from female (a) as well as male (b) rats. Vehicles are depicted in open circles.
∗P < 0.05
when treatment with genistein was compared to the corresponding vehicle.
activity was evidenced with diaminobenzidine in an Eclipse
50i NIKON light microscope equipped with a video camera
Nikon DS-SM. All groups were simultaneously processed to
prevent interassay diﬀerences. CGRP-immunoreactive ﬁbers
were quantiﬁed in second arterial branches. Relative area
(stained/total area) per ﬁeld and the diﬀerence between
anti-CGRP-incubatedtissuesandthecorrespondingcontrols
were measured. Morphometric analysis was performed with
Image J software (1.34 S National Institutes of Health USA).
2.5. Drugs. (−)-Noradrenaline bitartrate, genistein, and
daidzein were obtained from Sigma-Aldrich (St Louis, MI,
USA). Fulvestrant (Faslodex) was kindly donated by Astra
Zeneca.AnandamidewaspurchasedfromCaymanChemical
(Ann Arbor, MI, USA).
2.6. Statistical Analysis. Data are presented as the mean ±
SEM (n = 4 to 6) of the percent reductions of the initial
contraction to NA and were analyzed by two-way analysis
of variance followed by Bonferroni’s post hoc t-test.O n e -
wayanalysisofvariancefollowedbyDunnett’smultiplecom-
parison tests were performed for the immunohistochemical
assays as well as for noradrenaline-induced contractions. In
all the cases, a P<0.05 was considered as signiﬁcant.
3. Results
As shown in Figure 1, the endocannabinoid anandamide
reduced,inaconcentration-dependentmanner,thetransient
contractions elicited by 10nmol NA in mesenteric beds
isolated from either male or female Sprague-Dawley rats.
The oral administration of the phytoestrogen genistein
(10mg/kg; daily during 3 days) signiﬁcantly potentiated the
eﬀectofanandamideinmesentericbedsisolatedfromfemale
but not from male mesenteric beds.
In turn, a 3-day treatment with the soy-derived phytoe-
strogen daidzein did not modify the anandamide-induced
reduction of contractile responses when administered at a
dose of 10mg/kg to either female (Figure 2(a)) or male rats
(Figure 2(b)) but did signiﬁcantly increase the anandamide
eﬀects in mesenteries isolated from female rats when dose
was scaled up to 20mg/kg (Figure 2(c)).
The oral administration of the phytoestrogen genistein
(10mg/kg; daily during 3 days) signiﬁcantly potentiated the
eﬀectofanandamideinmesentericbedsisolatedfromfemale
but not from male mesenteric beds.
Twenty-one days after ovariectomy, the ability of anan-
damide to decrease the contractile response to NA in
mesenteric arteries declined signiﬁcantly (compare intact
females in Figure 1 and untreated OVX females in Figure 3;
P<0.001). Figure 3 shows that a 3-day treatment with
either 10mg/kg genistein or 20mg/kg daidzein could restore
anandamide-induced vascular eﬀects in OVX rats. On the
other hand, no eﬀects were evidenced by treatment with
10mg/kg daidzein (Figure 3(b)).
The estrogen receptor antagonist fulvestrant
(2.5mgkg−1, s.c. during 3 days) did not modify per se the
anandamide-induced reductions of precontracted arteries
either in intact (Figure 4(a))o ri nO V X( Figure 5(a))
females rats but signiﬁcantly prevented the potentiation
on anandamide-induced eﬀects caused by either 10mg/kg
genistein or, 20mg/kg daidzein in intact (Figures4(b) and
4(c))a sw e l la si nO V Xf e m a l er a t s( F i g u r e s5(b) and 5(c)).
As shown in Figure 6, the density of the CGRP-containing
ﬁberssurroundingmesentericarterieswasmarkedlyreduced4 International Journal of Hypertension
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Figure 2: Eﬀects of 3-day oral administration of either 10mg/kg or 20mg/kg daidzein (ﬁlled circles) on anandamide-induced reductions of
contractileresponses toNA inmesentericvascular bedsisolated fromfemale (a)and(c)as well as male(b)and(d)rats.Vehicles aredepicted
in open circles.
∗P < 0.05 when treatment with daidzein was compared to the corresponding vehicle.
by ovariectomy and signiﬁcantly restored after a 3-day oral
treatment with 10mg/kg genistein. Moreover, when animals
were concomitantly treated with genistein and fulvestrant,
the enhancing eﬀect of genistein was not observed. A similar
proﬁle was found after a 3-day oral treatment with 20mg/kg
but not with 10mg/mg daidzein (Figure 7).
4. Discussion
The present study shows that oral administration of the soy-
derived phytoestrogens genistein and daidzein daily during
3 days enhanced the decrease in the contractile responses to
NA induced by anandamide in mesenteric arteries isolated
from female but not from male rats. Taking into account
that the anandamide eﬀect is already greater in female
mesenteries compared to males [16], the enhancing eﬀect
of the phytoestrogens shown here in female rats adds to
the overall sex diﬀerentiation in this model. The tissue was
selected because it represents a group of resistance vessels
that greatly contributes to the maintenance of the total
peripheral vascular resistance [17, 18]. Precontractions to
NA were used to resemble the eﬀects of the adrenergicInternational Journal of Hypertension 5
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Figure 3: Eﬀects of 3-day administration of 10mg/kg genistein in (a), 10mg/kg daidzein in (b), and 20mg/kg daidzein in (c) on the
anandamide-induced reductions of contractile responses to NA in mesenteric beds isolated from ovariectomized female rats. Vehicles are
depicted in open circles.
∗P < 0.05 when treatments were compared to the corresponding vehicles.
hyperactivity in vascular tissues that usually precedes the
onset of primary hypertension [12].
The observation that the anandamide-induced relax-
ations in the OVX rats were restored by a 3-day oral admin-
istration of phytoestrogens (present results) to the same
extent as that produced by 17β-estradiol administration [16]
suggests that a common site of action, namely, estrogen
r ec ept o r s(ER),c ouldbein v ol v edinbothcases.I ns up po rto f
this view is the ﬁnding that in intact as well as in OVX female
ratsthefacilitatoryeﬀectofphytoestrogenswascounteracted
by the ER antagonist fulvestrant.
Moreover, a direct eﬀect of phytoestrogens on the con-
tractility to NA is precluded on the basis that no diﬀerences
were observed in the responsiveness to NA between male6 International Journal of Hypertension
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Figure 4: Eﬀects of 3-day s.c. administration of 2.5mg/kg of fulvestrant on the anandamide-induced reductions of contractile responses
to NA in untreated (a), genisteintreated (10mg/kg; (b)), or daidzein-treated (20mg/kg; (c)) intact female rats. Either fulvestrant (ﬁlled
circles) or its vehicle (open circles) were administered concomitantly with the corresponding phytoestrogen treatment.
∗P < 0.05 when
phytoestrogen-treated were compared against phytoestrogen plus fulvestrant-treated intact female rats.
and age-matched female rats after treatment with genistein
or daidzein ([16] and present results).
The fact that, as previously observed for 17β-estradiol
[6], the 3-day oral treatment with either 10mg/kg genistein
or 20mg/kg daidzein restored the decrease in the density of
CGRP-containing perivascular ﬁbers in mesenteries isolated
from OVX rats could indicate that the modulation of CGRP
levels contributes, among other factors, to the ability of
phytoestrogens to potentiate the eﬀect of anandamide in the
mesenteric vasculature. In addition, this ﬁnding is supported
on the basis that the presence of fulvestrant completely
prevented the enhancing eﬀect of phytoestrogens on CGRPInternational Journal of Hypertension 7
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Figure 5: Eﬀects of 3-day s.c. administration of 2.5mg/kg of fulvestrant on the anandamide-induced reductions of contractile responses to
NA in untreated (a), genistein-treated (10mg/kg; (b)), or daidzein-treated (20mg/kg; (c)) OVX female rats. Fulvestrant (ﬁlled circles) or its
vehicle (open circles) were concomitantly administered with the corresponding phytoestrogen treatment. ∗P<0.05 when phytoestrogen-
treated were compared against phytoestrogen plus fulvestrant-treated OVX female rats.
perivascular levels. This hypothesis agrees with previous
evidence showing that mesenteric availability of CGRP
underlies the ability of anandamide to reduce the contractile
responses toNAin mesentericarteries[6].Similarly,acause-
eﬀect relationship between estrogen levels and CGRP arises
from the observation that CGRP-containing ﬁbers density is
faded after ovariectomy and restored by estradiol treatment
in sensory and perivascular neurons [6, 19]. Speciﬁcally
related to phytoestrogens, it was reported that a diet with
fujiﬂavone P40, a soybean isoﬂavone product, completely
reverses the decrease in the levels of the mRNA coding
for CGRP in dorsal root ganglion neurons, as well as the8 International Journal of Hypertension
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Figure 6:ImmunohistochemistryforCGRP.(a)RepresentativemicrophotographsofCGRP-immunoreactiveﬁberssurroundingmesenteric
arteries in myenteric plexus preparations of sham-operated as well as of OVX female rats. Either genistein (10mg/kg p.o.) or genistein plus
fulvestrant (10mg/kg p.o. and 2.5mg/kg s.c., resp.) were administered daily during 3 days. The photomicrographs were captured at 400x
magniﬁcation; the scale bar indicates 50μm. (b) Bars represent the mean ± SEM (n = 4) of relative morphometric units measured as stained
area/total area. Speciﬁc immunoreactivity in every tissue was calculated as the diﬀerence between anti-CGRP-incubated and nonprimary
antibody-incubated samples. #P < 0.001 between sham and untreated-ovariectomized female rats.
∗P < 0.01 between genistein-treated and
either genistein plus fulvestrant-treated or the corresponding vehicle-treated OVX rats.
diminutions of the gastric tissue levels of CGRP in OVX
rats [20]. In this sense, the lack of eﬀect of oral treatment
with 10mg/kg daidzein agrees with the present observation
that 10mg/kg daidzein did not counteract the decrease in
mesenteric CGRP content caused by OVX. This observation
is consistent with previous evidence showing that genistein
is 10 to 100 times more potent than daidzein and that this
diﬀerence is linked to a higher aﬃnity of genistein for ER [8],
as observed for the modulation of the expression of enzymes
that metabolize 17 α-estradiol in cultured MCF-7 cells [21].
Ontheotherhand,thefactthatphytoestrogensenhanced
anandamide-induced eﬀects selectively in the vasculature of
female rats (present results) diﬀers from the potentiation
caused by 17β-estradiol in this tissue that is only observed
in males [16]. This discrepancy could arise from the fact
that the sex-related diﬀerences in the rat vasculature, which
include variations in the density and distribution of ER
subtypes [22], could only become evident when tissues are
exposed to compounds, such as genistein and daidzein, that
are known to possess a 1000-times lower estrogenic activity
than estradiol and are supposed to act as ERbeta partial
agonist [8]. In accordance to this, vasodilation to genistein
but not to 17β-estradiol is enhanced in postmenopausal
women suﬀering coronary heart disease that express high
ERbeta in the vascular wall [23] .H o w e v e r ,am o r ee x t e n s i v e
analysis of the estrogen receptor subtypes involved in the
vascular eﬀects of anandamide, including variations in the
density and distribution of ER subtypes in the mesenteric
bed of male and female Sprague-Dawley rats, is necessary to
reinforce this possibility.
Moreover, the lack of eﬀect of phytoestrogens in males
(present results) could rely on the fact that phytoestrogens
modify male gonadal steroids levels [24, 25]. In support
of the latter, it was reported that the control of anxiety-
related behaviours produced by the systemic administration
of phytoestrogens in male rats depends on the gonadal status
[26].
At the molecular level, the fatty acid amidohydrolase
(FAAH), the major anandamide-hydrolyzing enzyme, is
a potential locus for an interaction between oestrogensInternational Journal of Hypertension 9
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Figure 7:ImmunohistochemistryforCGRP.(a)RepresentativemicrophotographsofCGRP-immunoreactiveﬁberssurroundingmesenteric
arteries in myenteric plexus preparations of OVX female rats. Daidzein (10mg/kg or 20mg/kg p.o.) or daidzein plus fulvestrant (20mg/kg
p.o. and 2.5mg/kg s.c., resp.) were administered daily during 3 days. The photomicrographs were captured at 400x magniﬁcation; the
scale bar indicates 50μm. (b) Bars represent the mean ± SEM (n = 4) of relative morphometric units measured as stained area/total
area. Speciﬁc immunoreactivity in every tissue was calculated as the diﬀerence between anti-CGRP-incubated and nonprimary antibody-
incubated samples.
∗P < 0.01 between daidzein-treated (20mg/kg) and either daidzein plus fulvestrant-treated or untreated OVX rats.
and endocannabinoid signalling. The FAAH enzyme pos-
sesses an oestrogen response element in its genetic sequence,
and translocation of the oestrogen receptor to the nucleus
results in inhibition of FAAH transcription that leads to an
increase in the anandamide signalling [27]. Since genistein
and daidzein inhibit the fatty acid amidohydrolase in vitro
[11], the possibility exists that, at least in part, the modu-
latory eﬀect of phytoestrogens on the anandamide-induced
reductions of the contractility to NA could involve the
increase of anandamide levels. Nevertheless, this possibility
is likely to be precluded since the FAAH inhibitor PMSF is
devoid of eﬀects on anandamide-induced vasodilations in
theratmesentericvascularbedsisolatedfromeithersex[16],
as well on anandamide actions in other rat tissues, namely,
the brain [28].
In conclusion, this is the ﬁrst evidence that the soy-
derived phytoestrogens, genistein and daidzein, modulate
positively the reduction of the contractility to NA produced
by anandamide in the mesenteric vasculature and supports
the hypothesis that the endocannabinoid system could be
a target for the beneﬁcial cardiovascular actions of dietary
phytoestrogens, as proposed before for estrogens [5].
Finally, the present results give further support to the
view that a dietary intervention with an isoﬂavone-enriched
soy extract, acting at the cardiovascular level with minimal
impact in the reproductive tract, could have implications
for women’s cardiovascular health, for example, enhancing
the vasorelaxation of small arteries whenever increased
adrenergic hyperactivity occurs [23].
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